There were 1,771 press releases posted in the last 24 hours and 429,980 in the last 365 days.

XOM, IRTC & TSN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm

NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. 

Exxon Mobil Corporation (NYSE: XOM)
Class Period: February 28, 2018 - January 14, 2021
Deadline: March 29, 2021
For more info: www.bgandg.com/xom
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors that: (1) Exxon forced its employees to use unrealistic assumptions regarding the timelines for well drilling in the Permian Basin; (2) the foregoing assumptions served to artificially inflate the value of the Company's well operations in the Permian Basin; (3) the foregoing conduct, when revealed, subjected Exxon to a heightened risk of regulatory investigation and oversight; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.

iRhythm Technologies, Inc. (NASDAQ: IRTC)
Class Period: August 4, 2020 - January 28, 2021
Deadline: April 2, 2021
For more info: www.bgandg.com/irtc
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors that: (1) iRhythm’s business would suffer as a result of the U.S. Centers for Medicare and Medicaid Services’ (“CMS”) rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and (4) as a result of the foregoing, the iRhythm Defendants’ public statements were materially false and misleading at all relevant times.

Tyson Foods, Inc. (NYSE: TSN)
Class Period: March 13, 2020 - December 15, 2020
Deadline: April 5, 2021
For more info: www.bgandg.com/tsn
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors that: (1) Tyson Foods, Inc. ("Tyson") knew, or should have known, that the highly contagious coronavirus was spreading throughout the globe; (2) Tyson did not in fact have sufficient safety protocols to protect its employees in its facilities; (3) as a result, Tyson employees contracted and spread the coronavirus within the facilities; (4) as a result of the foregoing, Tyson would face negative impact to its production, including complete shutdowns of certain facilities; (5) due to the failure to protect its employees, Tyson would suffer financial harm related to its lowered production; and (6) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.